Common Stock SEC Reporting - Current
OTCQX International
Verified Company Profile 9/01/2017
Contact Info
  • Unit 2, 23F, New World Tower I
  • 18 Queens Road
  • Central Hong Kong, S
  • Hong Kong

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 20-F
CIK 0001456787
Fiscal Year End 3/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 5912 - Drugstores and Proprietary Stores
Incorporated In: Virgin Islands (British)
Year of Inc. 2008
Employees 11 a/o Aug 30, 2017
Company Officers/Contacts
Yat Man Lai CEO
Kwok Wing Fung CFO
Wing Mui Phoenix Ngai Secretary
Company Directors
Lok Bun Law Chairman
Tai Tze Yu Daniel Independent Director, Audit Committee Member
Kwok Wing Fung
Yat Man Lai
Lo Tsz Fung Philip Independent Director, Audit Committee Member
Service Providers
Accounting/Auditing Firm
Centurion ZD CPA Limited
Room 2105, Langham Place Office Tower, 8 Argyle Street,
359-361 Queen's Road Central
Hong Kong,
Securities Counsel
Ortoli Rosenstadt LLP OTCQX Sponsor
501 Madison Avenue
14th Floor
New York, NY, 10022
United States
Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States
Company History
  • Sponsored by Ortoli Rosenstadt LLP for OTCQX on September 21, 2017
DGJI Security Details
Share Structure
Market Value1 $71,154,149 a/o Jan 16, 2018
Authorized Shares 100,000,000 a/o Aug 08, 2014
Outstanding Shares 56,923,319 a/o Sep 14, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,603,790 a/o Aug 22, 2017
Par Value No Par Value
Transfer Agent(s)
Pacific Stock Transfer Co.
Shareholders of Record 135 a/o Aug 22, 2017
Short Selling Data
Short Interest 286 (-20.78%)
Dec 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security